FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, S. C.
Right arrow Articles by Larrick, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, S. C.
Right arrow Articles by Larrick, J. W.

The FASEB Journal, Vol 8, 654-660, Copyright © 1994 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Inhibition of apoptosis as a mechanism of tumor promotion

SC Wright, J Zhong and JW Larrick
Palo Alto Institute of Molecular Medicine, Mountain View, California 94043.

Recent evidence supports the concept that tumor growth in vivo depends on evasion of normal homeostatic control mechanisms that operate through induction of cell death by apoptosis. This study tested the hypothesis that a common property shared by known or suspected tumor promoters is the ability to block the process of apoptosis. A total of 10 tumor promoters were tested and all were found to inhibit DNA fragmentation and cell death of 7 different cell lines triggered into apoptosis by diverse agents. Resistance to apoptosis could be induced rapidly (within 1 h) by treating with relatively high concentrations of promoters. However, low physiological concentrations of promoters could also induce complete resistance to apoptosis after prolonged exposure (5-15 days of culture). Like tumor promotion in vivo, promoter-induced resistance to apoptosis was reversible after culturing in the absence of promoter. These findings provide new insight into the mechanism of tumor promotion and suggest a novel in vitro screening assay to detect new tumor-promoting agents in the environment.


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
V. Ramnath, P. S. Rekha, G. Kuttan, and R. Kuttan
Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin
Evid. Based Complement. Altern. Med., November 1, 2007; (2007) nem099v1.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
J. R. Inglefield, C. J. Larson, S. J. Gibson, H. Lebrec, and R. L. Miller
Apoptotic Responses in Squamous Carcinoma and Epithelial Cells to Small-Molecule Toll-like Receptor Agonists Evaluated with Automated Cytometry
J Biomol Screen, September 1, 2006; 11(6): 575 - 585.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
J. Tsurutani, S.S. Castillo, J. Brognard, C. A. Granville, C. Zhang, J. J. Gills, J. Sayyah, and P. A. Dennis
Tobacco components stimulate Akt-dependent proliferation and NF{kappa}B-dependent survival in lung cancer cells
Carcinogenesis, July 1, 2005; 26(7): 1182 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. K. Katiyar, A. M. Roy, and M. S. Baliga
Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation
Mol. Cancer Ther., February 1, 2005; 4(2): 207 - 216.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. M. Roy, M. S. Baliga, and S. K. Katiyar
Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation
Mol. Cancer Ther., January 1, 2005; 4(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W.-S. Hor, W.-L. Huang, Y.-S. Lin, and B.-C. Yang
Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils
J. Leukoc. Biol., March 1, 2003; 73(3): 363 - 368.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-T. Lin, C.-Y. Juan, K.-J. Chang, W.-J. Chen, and M.-L. Kuo
IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1
Carcinogenesis, December 1, 2001; 22(12): 1947 - 1953.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. Mukhtar and N. Ahmad
Tea polyphenols: prevention of cancer and optimizing health
Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1698S - 1702.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. E Burow, Y. Tang, B. M. Collins-Burow1, S. Krajewski, J. C. Reed, J. A. McLachlan, and B. S Beckman
Effects of environmental estrogens on tumor necrosis factor {alpha}-mediated apoptosis in MCF-7 cells
Carcinogenesis, November 1, 1999; 20(11): 2057 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. H. Holmstrom, S. E. F. Tran, V. L. Johnson, N. G. Ahn, S. C. Chow, and J. E. Eriksson
Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis
Mol. Cell. Biol., September 1, 1999; 19(9): 5991 - 6002.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin
Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS
J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-L. Kuo, S.-G. Shiah, C.-J. Wang, and S.-E. Chuang
Suppression of Apoptosis by Bcl-2 to Enhance Benzene Metabolites-Induced Oxidative DNA Damage and Mutagenesis: A Possible Mechanism of Carcinogenesis
Mol. Pharmacol., May 1, 1999; 55(5): 894 - 901.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
C. Huang, W.-y. Ma, A. Goranson, and Z. Dong
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Carcinogenesis, February 1, 1999; 20(2): 237 - 242.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The Federation of American Societies for Experimental Biology.